Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on Jul 13, 2022 5:00pm
152 Views
Post# 34822159

RE:RE:RE:Weak stock price reaction

RE:RE:RE:Weak stock price reactionI am sure management expected a better price jump on today's news. Perhaps they will start getting serious about the huge hole they have dug for themselves in regards to the capital markets. You simply cannot ignore investors like TH has. The continued low volume today shows they have totally lost any consistent following for the stock other than us here on this board. Fortunately, it is fixable but they need to first identify the problem. The absence of communication from the the company recently suggests nothing has changed yet though. If they have great news tomorrow (and it seems early for that), the stock would likely do better than today but far worse than it should had they not shut down communications for so long.
Lee430 wrote: Pleeeeez Thera announces something tomorror so amazing that even Mr. Market can't ignore us any longer.


<< Previous
Bullboard Posts
Next >>